Sir
Andrew Philip Witty is the CEO of pharmaceutical giant GlaxoSmithKline. He was
born on August 22, 1964 and earned a BA in Economics from the University of
Nottingham. Andrew was knighted in 2012 New Year Honours for services to the
economy and the UK pharmaceutical industry.
In
1985 he joined Glaxo UK as a management trainee. He rose through the ranks and
held a number of positions in the UK such as Director of Pharmacy &
Distribution in Glaxo Pharmaceuticals UK, Director of Business Development of
Biocompatibles Limited and International Product Manager of Glaxo Holdings PLC.
Andrew has also served outside of the UK
as Managing Director of Glaxo South Africa and Area Director of South and East
Africa.
His
expertise has also been used outside of Glaxo from 2000 to 2002 serving as an
economic adviser to the Governor of Guangzhou, China.
After
further promotions he was appointed President, Pharmaceuticals Europe of
GlaxoSmithKline plc in January 2003. Following the retirement of Dr. Jean-Pierre
Garnier in May 2008 he succeeded as CEO.
In
late 2012, it was revealed that Andrew had been appointed
the 7th Chancellor of the University of Nottingham effective January
1, 2013.
No comments:
Post a Comment